Key result
A meta-analysis of 8 studies evaluated the bleeding risk and procedure-related complications of uninterrupted warfarin therapy during coronary angiography, though specific results were truncated.
Why the study?
Does uninterrupted warfarin therapy increase bleeding risk and procedure-related complications in patients undergoing coronary angiography and percutaneous coronary intervention?
Meta-Analysis
Does uninterrupted warfarin therapy increase bleeding risk and procedure-related complications in patients undergoing coronary angiography and percutaneous coronary intervention?
This meta-analysis evaluates the safety of performing coronary angiography and PCI without interrupting warfarin therapy.
Informs periprocedural anticoagulation decisions in warfarin patients; extends prior data via pooled analysis of 8 studies.
Objective: A systematic review of the literature was conducted relating to the continuation of warfarin therapy at the time of coronary angiography, with or without percutaneous coronary intervention, to determine the bleeding risk of these patients. Methods: A search of a major electronic database was independently conducted by two reviewers from 1960 to December 2009. Studies were included if they met the following criteria: were original; included patients who were undergoing coronary angiography/catheterization with or without angioplasty/stent placement and were receiving uninterrupted warfarin therapy throughout the periprocedural period; and reported the number of bleeding events and procedure related complications. Based on the inclusion and exclusion criteria, a total of eight studies (one randomized, four cohort and three case series) were included for analysis. Results: The pooled odds ratio (95% CI) for procedure-related complications in continued warfarin versus nonanticoagulated patients, in...
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2011) conducted a meta-analysis in Coronary angiography and percutaneous coronary intervention. Uninterrupted warfarin therapy vs. Nonanticoagulated patients was evaluated on Bleeding events and procedure-related complications. A meta-analysis of 8 studies evaluated the bleeding risk and procedure-related complications of uninterrupted warfarin therapy during coronary angiography, though specific results were truncated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: